Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers.

Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF.

Clin Neurophysiol. 2004 Jan;115(1):194-8.

PMID:
14706488
2.

Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals.

Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF.

Clin Neurophysiol. 2003 Mar;114(3):410-5.

PMID:
12705421
3.

Performance and brain electrical activity during prolonged confinement.

Lorenz B, Lorenz J, Manzey D.

Adv Space Biol Med. 1996;5:157-81.

PMID:
8814797
4.

Task-related EEG and ERP changes without performance impairment following a single dose of phenytoin.

Chung SS, McEvoy LK, Smith ME, Gevins A, Meador K, Laxer KD.

Clin Neurophysiol. 2002 Jun;113(6):806-14.

PMID:
12048040
5.

Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH.

Psychopharmacology (Berl). 2006 Oct;188(2):162-70. Epub 2006 Aug 17.

PMID:
16915378
6.

Cannabinoid modulations of resting state EEG θ power and working memory are correlated in humans.

Böcker KB, Hunault CC, Gerritsen J, Kruidenier M, Mensinga TT, Kenemans JL.

J Cogn Neurosci. 2010 Sep;22(9):1906-16. doi: 10.1162/jocn.2009.21355.

PMID:
19803687
7.

Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures.

Salinsky MC, Oken BS, Storzbach D, Dodrill CB.

Epilepsia. 2003 Aug;44(8):1042-50.

8.

Attentional control and brain metabolite levels in methamphetamine abusers.

Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, Buonocore MH.

Biol Psychiatry. 2007 Jun 1;61(11):1272-80. Epub 2006 Nov 9.

PMID:
17097074
10.

Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.

Kalechstein AD, De la Garza R 2nd, Newton TF, Green MF, Cook IA, Leuchter AF.

J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):254-8. doi: 10.1176/appi.neuropsych.21.3.254.

11.

Effects of intranasal methamphetamine on metacognition of agency.

Kirkpatrick MG, Metcalfe J, Greene MJ, Hart CL.

Psychopharmacology (Berl). 2008 Mar;197(1):137-44. Epub 2007 Nov 28.

PMID:
18043908
12.

Methamphetamine-induced neural and cognitive changes in rodents.

Marshall JF, Belcher AM, Feinstein EM, O'Dell SJ.

Addiction. 2007 Apr;102 Suppl 1:61-9. Review.

PMID:
17493054
13.

Clinical correlates of quantitative EEG alterations in alcoholic patients.

Coutin-Churchman P, Moreno R, Añez Y, Vergara F.

Clin Neurophysiol. 2006 Apr;117(4):740-51. Epub 2006 Feb 21.

PMID:
16495144
14.

Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.

Mahoney JJ 3rd, Jackson BJ, Kalechstein AD, De La Garza R 2nd, Newton TF.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):459-65. doi: 10.1016/j.pnpbp.2010.11.034. Epub 2010 Nov 29.

15.

Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition.

Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y.

Psychopharmacology (Berl). 2005 Mar;178(2-3):296-302. Epub 2004 Sep 25.

PMID:
15452681
16.

Test-retest reliability of cognitive EEG.

McEvoy LK, Smith ME, Gevins A.

Clin Neurophysiol. 2000 Mar;111(3):457-63.

PMID:
10699407
17.

Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.

Saletu M, Anderer P, Semlitsch HV, Saletu-Zyhlarz GM, Mandl M, Zeitlhofer J, Saletu B.

Psychiatry Res. 2007 Jan 15;154(1):69-84. Epub 2006 Dec 20.

PMID:
17187965
18.

Central effects of the diuretic, bendrofluazide.

McDevitt DG, Currie D, Nicholson AN, Wright NA, Zetlein MB.

Br J Clin Pharmacol. 1994 Sep;38(3):249-56.

19.

Altered central nervous system signal during motor performance in chronic fatigue syndrome.

Siemionow V, Fang Y, Calabrese L, Sahgal V, Yue GH.

Clin Neurophysiol. 2004 Oct;115(10):2372-81.

PMID:
15351380
20.

The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

Silber BY, Croft RJ, Papafotiou K, Stough C.

Psychopharmacology (Berl). 2006 Aug;187(2):154-69. Epub 2006 Jun 8.

PMID:
16761129

Supplemental Content

Support Center